This section provides additional resources for individuals interested in antimicrobial stewardship programs, including Materials and Forms, US Academic Medical Centers Online Stewardship Resources, International Online Stewardship Resources, and Other Resources.  Please note that these resources are not endorsed by SHEA and are shared for informational purposes only.  If you have resources to add, please send them to  Note: Inclusion in this list does not indicate endorsement by SHEA.

Below are examples of antimicrobial initiatives underway in other organizations, institutions, state and federal agencies, and internationally.

Pediatric Antimicrobial Stewardship is just as if not more important than adult stewardship program. These resources are specific for pediatric use.

On September 18, 2014, the Obama Administration released a coordinated effort related to antimicrobial resistance and stewardship. The links to the key materials released are below. Expect to see more from SHEA on antimicrobial stewardship as we focus on our strategy moving forward. Several SHEA members were on the President's Council of Advisors on Science and Technology (PCAST) and we are pleased that their expertise and leadership on this critical issue was recognized. As of March 2015, the White House released a National Action Plan for Combatting Antibiotic-Resistant Bacteria.  SHEA continues to follow and provide input on this plan.

SHEA has partnered with IDSA for over a decade to develop treatment guidelines and programmatic recommendations for antimicrobial stewardship.

The SHEA Research Network invites investigators to submit research proposals focused on antimicrobial stewardship.  Investigators interested in engaging the Network for a study should complete the Study Proposal Concept Form and submit it to or fax: (703) 684-1009.

Antibiotic stewardship refers to a set of coordinated strategies to improve the use of antimicrobial medications with the goal of enhancing patient health outcomes, reducing resistance to antibiotics, and decreasing unnecessary costs.

The discovery of antibiotic treatments transformed healthcare, and dramatically improved our ability to reduce morbidity and mortality for all clinical areas, especially in surgery, transplant medicine, oncology and intensive care medicine.